BISPEXDUR
Live / Applied — Fourth extension granted (statement of use) (as of 10 May 2025)
What this means for you
Not registered yet, but its 19 Jul 2022 filing date beats anything filed after it. If it registers, the owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 97509952
- Mark type
- Stylized text
- Filed
- 19 Jul 2022
- Published for opposition
- 11 Apr 2023
- Attorney of record
- Terrence J. McAllister
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations for the treatment of hematological, gastrointestinal, neuromuscular, muscular, cardiovascular, metabolic, immunological, inflammatory, oncological, ophthalmological, neurological, musculoskeletal, bone, connective tissue, dermatological, infectious, autoimmune, nephrological, hepatological, allergic, genetic, respiratory, and viral diseases and disorders; Pharmaceutical preparations for the treatment of pain
Owner
- Regeneron Pharmaceuticals, Inc., Tarrytown, NY, US
- Regeneron Pharmaceuticals, Inc., Tarrytown, NY, US
Prosecution history
- 06 Dec 2025 — SOU TEAS EXTENSION RECEIVED
- 30 Jun 2025 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
- 30 Jun 2025 — APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
- 30 Jun 2025 — TEAS CHANGE OF OWNER ADDRESS RECEIVED
- 10 May 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 10 May 2025 — SOU EXTENSION 4 GRANTED
- 10 May 2025 — SOU EXTENSION 4 FILED
- 09 May 2025 — SOU TEAS EXTENSION RECEIVED
- 03 Mar 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 20 Nov 2024 — SOU EXTENSION 3 GRANTED
- 20 Nov 2024 — SOU EXTENSION 3 FILED
- 19 Nov 2024 — SOU TEAS EXTENSION RECEIVED
- 15 May 2024 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 14 May 2024 — SOU EXTENSION 2 GRANTED
- 14 May 2024 — SOU EXTENSION 2 FILED